{"name": "BioMarin Pharmaceutical",
 "permalink": "biomarin-pharmaceutical",
 "crunchbase_url": "http://www.crunchbase.com/company/biomarin-pharmaceutical",
 "homepage_url": "http://www.bmrn.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Tue Jan 26 07:09:40 UTC 2010",
 "updated_at": "Wed Aug 18 18:09:17 UTC 2010",
 "overview": "\u003Cp\u003EBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company\u0026#8217;s product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme\u00c2\u00ae (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme\u00c2\u00ae (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan\u00c2\u00ae (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       33],
      "assets/images/resized/0007/4854/74854v1-max-150x150.jpg"],
     [[250,
       55],
      "assets/images/resized/0007/4854/74854v1-max-250x250.jpg"],
     [[317,
       71],
      "assets/images/resized/0007/4854/74854v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "Sr. Manager, Regulatory Affairs",
    "person":
     {"first_name": "Scott",
      "last_name": "Harris",
      "permalink": "scott-harris",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 58500000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercebiotech.com/story/biomarin-snares-orphan-disease-upstart-115m-buyout/2010-08-18?utm_medium=rss\u0026utm_source=rss",
    "source_description": "BioMarin Acquires Huxley Pharmaceuticals, Inc.",
    "acquired_year": 2009,
    "acquired_month": 10,
    "acquired_day": 26,
    "company":
     {"name": "Huxley Pharmaceuticals",
      "permalink": "huxley-pharmaceuticals",
      "image": null}},
   {"price_amount": 115000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercebiotech.com/story/biomarin-snares-orphan-disease-upstart-115m-buyout/2010-08-18?utm_medium=rss\u0026utm_source=rss",
    "source_description": " BioMarin snares orphan drug upstart in $115M buyout",
    "acquired_year": 2010,
    "acquired_month": 8,
    "acquired_day": 18,
    "company":
     {"name": "Zystor",
      "permalink": "zystor",
      "image":
       {"available_sizes":
         [[[100,
            101],
           "assets/images/resized/0009/8353/98353v1-max-150x150.jpg"],
          [[100,
            101],
           "assets/images/resized/0009/8353/98353v1-max-250x250.jpg"],
          [[100,
            101],
           "assets/images/resized/0009/8353/98353v1-max-450x450.jpg"]],
        "attribution": null}}},
   {"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://finance.yahoo.com/news/biomarin-acquires-zacharon-pharmaceuticals-140000903.html",
    "source_description": "BioMarin Acquires Zacharon Pharmaceuticals",
    "acquired_year": 2013,
    "acquired_month": 1,
    "acquired_day": 7,
    "company":
     {"name": "Zacharon Pharmaceuticals",
      "permalink": "zacharon-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[150,
            59],
           "assets/images/resized/0022/8810/228810v1-max-150x150.jpg"],
          [[229,
            91],
           "assets/images/resized/0022/8810/228810v1-max-250x250.jpg"],
          [[229,
            91],
           "assets/images/resized/0022/8810/228810v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}